Christophe Bergeron
- Pulmonary and Respiratory Medicine top 0.5%
- Molecular Biology top 5%
- Neurology top 0.5%
- Oncology top 2%
- Pathology and Forensic Medicine top 1%
- Co-authors
- Norbert GrafKathy Pritchard‐JonesHarm van TinterenJean MichonJan de KrakerDaniel OrbachDominique PlantazOlivier Hartmann
- Topics
- Renal and related cancers (52 papers)Neuroblastoma Research and Treatments (39 papers)Sarcoma Diagnosis and Treatment (36 papers)
- Journals
- The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- FranceUnited KingdomNetherlands
In The Last Decade
Christophe Bergeron
171 papers receiving 5.3k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Pulmonary and Respiratory Medicine 2.5k
- Molecular Biology 2.1k
- Neurology 1.5k
- Oncology 1.3k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Christophe Bergeron
This map shows the geographic impact of Christophe Bergeron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Bergeron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Bergeron more than expected).
Fields of papers citing papers by Christophe Bergeron
This network shows the impact of papers produced by Christophe Bergeron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Bergeron. The network helps show where Christophe Bergeron may publish in the future.
Co-authorship network of co-authors of Christophe Bergeron
This figure shows the co-authorship network connecting the top 25 collaborators of Christophe Bergeron. A scholar is included among the top collaborators of Christophe Bergeron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christophe Bergeron. Christophe Bergeron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 21 | |
| 3 | 12 | |
| 4 | 52 | |
| 5 | 28 | |
| 6 | 149 | |
| 7 | 8 | |
| 8 | 24 | |
| 9 | 55 | |
| 10 | 81 | |
| 11 | 8 | |
| 12 | 37 | |
| 13 | 122 | |
| 14 | 61 | |
| 15 | 1 | |
| 16 | 4 | |
| 17 | 29 | |
| 18 | CLEAR CELL SARCOMA OF THE KIDNEY (CCSK) - COMBINED 20 YEAR EXPERIENCE OF THERAPUETIC OUTCOMES FROM UNITED KINGDOM (UK) AND FRANCE | 1 |
| 19 | 4 | |
| 20 | Focusing on rhabdomyosarcomas in children | 1 |
About Christophe Bergeron
Christophe Bergeron is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Pediatrics, Perinatology and Child Health, having authored 174 papers that have together received 5.4k indexed citations. Recurring topics across this work include Renal and related cancers (52 papers), Neuroblastoma Research and Treatments (39 papers) and Sarcoma Diagnosis and Treatment (36 papers). The work is most often cited by research in Neurology (1.5k citations), Pulmonary and Respiratory Medicine (2.5k citations) and Pathology and Forensic Medicine (1.1k citations). Christophe Bergeron has collaborated with scholars based in France, United Kingdom and Netherlands. Frequent co-authors include Norbert Graf, Kathy Pritchard‐Jones, Harm van Tinteren, Jean Michon, Jan de Kraker, Daniel Orbach, Dominique Plantaz, Olivier Hartmann, Marry M. van den Heuvel‐Eibrink and Johannes H. M. Merks. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.